Literature DB >> 11119400

Uncomplicated acute bronchitis.

R Gonzales1, M A Sande.   

Abstract

Acute bronchitis is an acute cough illness in otherwise healthy adults that usually lasts 1 to 3 weeks. This review describes the pathophysiology of the condition and provides a practical approach to the evaluation and treatment of adults with uncomplicated acute bronchitis. Practical points to be made are:1. Respiratory viruses appear to cause the large majority of cases of uncomplicated acute bronchitis.2. Pertussis infection is present in up to 10% to 20% of adults with cough illness of more than 2 to 3 weeks' duration. No clinical features distinguish pertussis from nonpertussis infection in adults who were immunized against pertussis as children.3. Transient bronchial hyperresponsiveness appears to be the predominant mechanism of the bothersome cough of acute bronchitis.4. Ruling out pneumonia is the primary objective in evaluating adults with acute cough illness in whom comorbid conditions and occult asthma are absent or unlikely. In the absence of abnormalities in vital signs (heart rate > 100 beats/min, respiratory rate > 24 breaths/min, and oral body temperature > 38 degrees C), the likelihood of pneumonia is very low.5. Randomized, placebo-controlled trials do not support routine antibiotic treatment of uncomplicated acute bronchitis.6. Randomized, placebo-controlled trials have shown that inhaled albuterol decreases the duration of cough in adults with uncomplicated acute bronchitis.7. Intervention studies suggest that antibiotic treatment of acute bronchitis can be reduced by using a combination of patient and physician education. Decreased rates of antibiotic treatment are not associated with increased utilization, return visits, or dissatisfaction with care.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11119400     DOI: 10.7326/0003-4819-133-12-200012190-00014

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  45 in total

1.  Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey.

Authors:  P Schuetz; M Batschwaroff; F Dusemund; W Albrich; U Bürgi; M Maurer; M Brutsche; A R Huber; B Müller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-12-29       Impact factor: 3.267

2.  Costs of childhood asthma due to traffic-related pollution in two California communities.

Authors:  Sylvia J Brandt; Laura Perez; Nino Künzli; Fred Lurmann; Rob McConnell
Journal:  Eur Respir J       Date:  2012-01-20       Impact factor: 16.671

3.  Agreement between emergency physician diagnosis and radiologist reports in patients discharged from an emergency department with community-acquired pneumonia.

Authors:  Samuel G Campbell; Daphne D Murray; Ammar Hawass; David Urquhart; Stacy Ackroyd-Stolarz; David Maxwell
Journal:  Emerg Radiol       Date:  2005-06

4.  Cost of near-roadway and regional air pollution-attributable childhood asthma in Los Angeles County.

Authors:  Sylvia Brandt; Laura Perez; Nino Künzli; Fred Lurmann; John Wilson; Manuel Pastor; Rob McConnell
Journal:  J Allergy Clin Immunol       Date:  2014-11-05       Impact factor: 10.793

5.  Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection.

Authors:  David T Huang; Donald M Yealy; Michael R Filbin; Aaron M Brown; Chung-Chou H Chang; Yohei Doi; Michael W Donnino; Jonathan Fine; Michael J Fine; Michelle A Fischer; John M Holst; Peter C Hou; John A Kellum; Feras Khan; Michael C Kurz; Shahram Lotfipour; Frank LoVecchio; Octavia M Peck-Palmer; Francis Pike; Heather Prunty; Robert L Sherwin; Lauren Southerland; Thomas Terndrup; Lisa A Weissfeld; Jonathan Yabes; Derek C Angus
Journal:  N Engl J Med       Date:  2018-05-20       Impact factor: 91.245

6. 

Authors:  J E Losa García; M R Martín de Cabo
Journal:  Medicine (Madr)       Date:  2013-04-03

7.  Which patients with lower respiratory tract infections need inpatient treatment? Perceptions of physicians, nurses, patients and relatives.

Authors:  Claudia Baehni; Sabine Meier; Pamela Spreiter; Ursula Schild; Katharina Regez; Rita Bossart; Robert Thomann; Claudine Falconnier; Mirjam Christ-Crain; Sabina De Geest; Beat Müller; Philipp Schuetz
Journal:  BMC Pulm Med       Date:  2010-03-11       Impact factor: 3.317

8.  Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance.

Authors:  F Dusemund; B Bucher; S Meyer; R Thomann; F Kühn; S Bassetti; M Sprenger; E Baechli; T Sigrist; M Schwietert; D Amin; P Hausfater; E Carre; P Schuetz; J Gaillat; K Regez; R Bossart; U Schild; B Müller; W C Albrich
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-12       Impact factor: 3.267

9.  Predictors of inappropriate antibiotic prescribing among primary care physicians.

Authors:  Genevieve Cadieux; Robyn Tamblyn; Dale Dauphinee; Michael Libman
Journal:  CMAJ       Date:  2007-10-09       Impact factor: 8.262

10.  Effect of antibiotic prescribing strategies and an information leaflet on longer-term reconsultation for acute lower respiratory tract infection.

Authors:  Michael Moore; Paul Little; Kate Rumsby; Jo Kelly; Louise Watson; Greg Warner; Tom Fahey; Ian Williamson
Journal:  Br J Gen Pract       Date:  2009-10       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.